Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics

Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics

In medicine and public health, the randomised controlled trial (RCT) is generally considered the key generator of ‘gold standard’ evidence. However, basic and clinical research and trials are often unrepresentative of real-world populations. Recruiting insufficiently diverse cohorts of participants...

Full description

Saved in:
Bibliographic Details
Main Authors: Laurence S.J. Roope, Jessica Walsh, Maddie Welland, Gabrielle Samuel, Heidi Johansen-Berg, Anna C. Nobre, Stuart Clare, Helen Higham, Jon Campbell, Tim Denison, Karla L. Miller, Seena Fazel, Matthew L. Costa, Andrew Farmer, Marian Knight, Rachel Taylor, Lorna R. Henderson, Angeli Vaid, John Geddes, Vasiliki Kiparoglou, Helen McShane, Philip M. Clarke
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Contemporary Clinical Trials Communications
Subjects:
Diversity
Efficient trial design
Inequality
Levelling up
Trial recruitment
Underserved
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865425000419
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2451865425000419

Similar Items